Pituitary Adenylate Cyclase-Activating Polypeptide Protects Glomerular Podocytes from Inflammatory Injuries

Diabetic nephropathy (DN) is a leading cause of end-stage kidney disease; however, there are few treatment options. Inflammation plays a crucial role in the initiation and/or progression of DN. Pituitary adenylate cyclase-activating polypeptide (PACAP) is a neuropeptide, which was originally isolate...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:J Diabetes Res
Prif Awduron: Sakamoto, Kenichi, Kuno, Kyoko, Takemoto, Minoru, He, Peng, Ishikawa, Takahiro, Onishi, Shunichiro, Ishibashi, Ryoichi, Okabe, Emiko, Shoji, Mayumi, Hattori, Akiko, Yamaga, Masaya, Kobayashi, Kazuki, Kawamura, Harukiyo, Tokuyama, Hirotake, Maezawa, Yoshiro, Yokote, Koutaro
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Hindawi Publishing Corporation 2015
Pynciau:
Research Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4363873/
https://ncbi.nlm.nih.gov/pubmed/25821833
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/727152
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg